LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 2 of 15: Cell count and relative growth within biological replicate 2. - Dataset (ID:20238)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Relative Growth Rate After Treatment |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | HG-5-113-01 | 3.33 | uM | LJP5 | 1 | B08 | 72 | hr | 2543 | 2027 | 5578 | 0.3634 | -0.1702 |
| SK-BR-3 | HG-5-113-01 | 3.33 | uM | LJP5 | 2 | B08 | 72 | hr | 2543 | 1912 | 5578 | 0.3427 | -0.2080 |
| SK-BR-3 | HG-5-113-01 | 3.33 | uM | LJP5 | 3 | B08 | 72 | hr | 2543 | 2209 | 5578 | 0.3960 | -0.1102 |
| SK-BR-3 | HG-5-88-01 | 3.33 | uM | LJP6 | 1 | A20 | 72 | hr | 2543 | 3844 | 5578 | 0.6891 | 0.4285 |
| SK-BR-3 | HG-5-88-01 | 3.33 | uM | LJP6 | 2 | A20 | 72 | hr | 2543 | 4162 | 5578 | 0.7461 | 0.5333 |
| SK-BR-3 | HG-5-88-01 | 3.33 | uM | LJP6 | 3 | A20 | 72 | hr | 2543 | 4110 | 5578 | 0.7367 | 0.5161 |
| SK-BR-3 | Imatinib | 3.33 | uM | LJP6 | 1 | N14 | 72 | hr | 2543 | 5025 | 5578 | 0.9008 | 0.8176 |
| SK-BR-3 | Imatinib | 3.33 | uM | LJP6 | 2 | N14 | 72 | hr | 2543 | 5932 | 5578 | 1.0633 | 1.1164 |
| SK-BR-3 | Imatinib | 3.33 | uM | LJP6 | 3 | N14 | 72 | hr | 2543 | 5901 | 5578 | 1.0578 | 1.1062 |
| SK-BR-3 | JNK-9L | 3.33 | uM | LJP6 | 1 | K20 | 72 | hr | 2543 | 1904 | 5578 | 0.3413 | -0.2107 |
| SK-BR-3 | JNK-9L | 3.33 | uM | LJP6 | 2 | K20 | 72 | hr | 2543 | 1985 | 5578 | 0.3558 | -0.1840 |
| SK-BR-3 | JNK-9L | 3.33 | uM | LJP6 | 3 | K20 | 72 | hr | 2543 | 1890 | 5578 | 0.3388 | -0.2153 |
| SK-BR-3 | JW-7-24-1 | 3.33 | uM | LJP6 | 1 | B20 | 72 | hr | 2543 | 2972 | 5578 | 0.5327 | 0.1412 |
| SK-BR-3 | JW-7-24-1 | 3.33 | uM | LJP6 | 2 | B20 | 72 | hr | 2543 | 3451 | 5578 | 0.6186 | 0.2990 |
| SK-BR-3 | JW-7-24-1 | 3.33 | uM | LJP6 | 3 | B20 | 72 | hr | 2543 | 3120 | 5578 | 0.5593 | 0.1900 |
| SK-BR-3 | Lapatinib | 3.33 | uM | LJP6 | 1 | M20 | 72 | hr | 2543 | 1968 | 5578 | 0.3528 | -0.1896 |
| SK-BR-3 | Lapatinib | 3.33 | uM | LJP6 | 2 | M20 | 72 | hr | 2543 | 2192 | 5578 | 0.3929 | -0.1158 |
| SK-BR-3 | Lapatinib | 3.33 | uM | LJP6 | 3 | M20 | 72 | hr | 2543 | 2341 | 5578 | 0.4196 | -0.0667 |
| SK-BR-3 | LDN-193189 | 3.33 | uM | LJP5 | 1 | G02 | 72 | hr | 2543 | 3726 | 5578 | 0.6679 | 0.3896 |
| SK-BR-3 | LDN-193189 | 3.33 | uM | LJP5 | 2 | G02 | 72 | hr | 2543 | 2353 | 5578 | 0.4218 | -0.0628 |
| SK-BR-3 | LDN-193189 | 3.33 | uM | LJP5 | 3 | G02 | 72 | hr | 2543 | 3116 | 5578 | 0.5586 | 0.1886 |
| SK-BR-3 | Linifanib | 3.33 | uM | LJP6 | 1 | J08 | 72 | hr | 2543 | 5337 | 5578 | 0.9567 | 0.9204 |
| SK-BR-3 | Linifanib | 3.33 | uM | LJP6 | 2 | J08 | 72 | hr | 2543 | 5481 | 5578 | 0.9825 | 0.9678 |
| SK-BR-3 | Linifanib | 3.33 | uM | LJP6 | 3 | J08 | 72 | hr | 2543 | 5543 | 5578 | 0.9936 | 0.9883 |
| SK-BR-3 | Linsitinib | 3.33 | uM | LJP5 | 1 | O20 | 72 | hr | 2543 | 4656 | 5578 | 0.8346 | 0.6960 |